Showing results (61-70 of 294) with videos related to
Sort By:
Pageof 30
Onkologie|February 1, 1987
[Advantages and problems of multicenter therapy studies exemplified by a study of the treatment of metastasizing renal cell carcinoma with recombinant interferon-alpha-2c]D Messerer, F Porzsolt, J Hasford, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1991
Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-gamma in cancer patientsW Digel, G Zahn, G Heinzel, et al.Leukemia & Lymphoma|January 1, 1994
Paracrine regulation of B-cell growth in hairy cell leukemiaF Porzsolt, M Schmid, G Staib, et al.Medizinische Klinik (Munich, Germany : 1983)|May 15, 1997
[Physicians' attitude in the treatment of incompetent patients. Comparison between East and West Germany]J Richter, M Eisemann, B Bauer, et al.International Journal of Oncology|May 17, 2011
Immunologically defined subclasses of the growth suppressor protein p53 detected with antibodies in sera from tumor patientsD Hoher, S Kartarius, F Porzsolt, et al.British Journal of Haematology|May 1, 1995
Evidence for a paracrine pathway of B-cell stimulation in hairy cell leukaemiaM Schmid, H Schrezenmeier, G Staib, et al.The Cochrane Database of Systematic Reviews|April 22, 2008
Targeted therapy for advanced renal cell carcinomaC Coppin, L Le, F Porzsolt, et al.MMW, Munchener Medizinische Wochenschrift|October 21, 1977
[First experience with the practical year in internal medicine (author's transl)]H Heimpel, J Schneider, R ZieglerActa Haematologica|January 1, 1983
Cytogenetic studies in chronic myeloproliferative disordersF Carbonell, A Ganser, H HeimpelThe Clinical Investigator|February 1, 1993
Granulocyte-macrophage colony-stimulating factor in the sera of patients with aplastic anemiaH Schrezenmeier, A Raghavachar, H HeimpelPageof 30